An independent guide to cash-pay care. Every price is dated and sourced.

How we check

Mounjaro with other medicines and health conditions

Three kinds of medicines get special mention on the Mounjaro label: insulin and sulfonylureas, because together they make low blood sugar more likely; birth control pills, which may lose some effect, so a non-oral or backup method is advised for 4 weeks after starting and after each dose increase; and oral drugs where small level changes matter, such as warfarin, which need monitoring because Mounjaro slows stomach emptying [1]. Zepbound's label adds that tirzepatide should not be combined with other tirzepatide products or any GLP-1 medicine [2].

Medical review: pending. A licensed clinician has not yet reviewed this page.

Mounjaro interactions are the ways other medicines and health conditions can change the safety of Mounjaro (tirzepatide), as set out in Sections 4, 5, 7 and 8 of its FDA label.

Birth control pills
Ethinyl estradiol peak 59% lower; backup for 4 weeks after start and each increase [1]
Insulin or sulfonylurea
Prescriber may lower their dose [1]
Narrow-margin pills
Monitor drugs such as warfarin [1]
Kidney or liver impairment
No dose adjustment on the label [1]
Approved for
Type 2 diabetes (age 10+), heart risk reduction in T2D; not weight loss [1]

Who Mounjaro is labeled for

Tirzepatide, the medicine in Mounjaro, acts on two hormone receptors, GIP and GLP-1 [1]. The label approves it for two things: blood sugar control in adults and children 10 and older with type 2 diabetes, and lowering major cardiovascular events in high-risk adults with type 2 diabetes [1]. Type 1 diabetes is not on that list, and neither is weight loss. Someone without diabetes who takes Mounjaro to lose weight is using it off-label; the tirzepatide brand labeled for weight management and obstructive sleep apnea is Zepbound [2]. The label differences are laid out on Mounjaro vs Zepbound.

Other diabetes drugs: insulin, sulfonylureas and metformin

Metformin does not appear as an interaction on the Mounjaro label. Insulin and sulfonylureas do: when Mounjaro is added, the prescriber may lower their doses to head off lows [1]. In trials with basal insulin, glucose under 54 mg/dL happened in 14% to 19% of people on Mounjaro and 13% on placebo; with a sulfonylurea the range was 9.9% to 13.8% [1]. Insulin and Mounjaro go in as two separate shots and are never mixed [1]. Per the Zepbound label, tirzepatide is not recommended alongside other tirzepatide products or GLP-1 drugs such as Ozempic [2]; the semaglutide side of this topic is on Ozempic interactions.

Birth control, warfarin, Tylenol and other pills

Because tirzepatide slows how fast the stomach empties, pills taken by mouth can be absorbed differently [1]. In a study with an oral contraceptive, the peak level of ethinyl estradiol dropped 59% and overall exposure dropped 20% [1]. So the label says to switch to a non-oral method, or add a barrier method, for 4 weeks after the first Mounjaro dose and for 4 weeks after every dose increase. Non-oral hormonal methods are not expected to be affected [1].

For medicines with a narrow safety margin, such as warfarin, the label calls for monitoring [1]. Acetaminophen (Tylenol) reached a 50% lower peak after a first 5 mg dose [1], but the label does not say to avoid it. Ibuprofen, antibiotics and phentermine are not mentioned. Check with a pharmacist before combining anything, keeping in mind that dehydration on Mounjaro has led to kidney injury [1]. Food, fluids and vitamin timing are on what to eat on Mounjaro.

Heart, blood pressure, kidneys, liver and eyes

  • Heart. Mounjaro gained an approval in August 2026 to lower heart attack, stroke and cardiovascular death in high-risk adults with type 2 diabetes [1]. Heart rate rose by an average of 2 to 4 beats per minute [1].
  • Blood pressure. The parts of the label we read report no blood pressure results. Ask whether your blood pressure medicines need a review.
  • Kidneys. The label recommends no dose change for kidney impairment. It does advise monitoring kidney function in people with kidney impairment who have severe stomach or bowel side effects, when starting or raising the dose, because acute kidney injury has been reported with dehydration [1].
  • Liver. No dose change is recommended for liver impairment [1]. Fatty liver disease is not a labeled use.
  • Eyes. A fast drop in blood sugar can briefly worsen diabetic retinopathy [1].
  • Stomach. Not recommended for people with severe gastroparesis [1].
  • Thyroid. Not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2 [1].

Pregnancy, birth control and breastfeeding

There are not enough human pregnancy data to judge the risk. The Mounjaro label allows use in pregnancy only when the potential benefit justifies the potential risk to the fetus [1]. If you could get pregnant and rely on the pill, the 4-week backup rule applies [1]. In a single-dose study of 11 nursing mothers, tirzepatide in breast milk was undetectable or low, under 0.02% of the mother's dose; effects on babies and on milk supply have not been studied [3]. Make a plan with your prescriber.

Anesthesia, sedation and procedures

Food or liquid getting into the lungs during general anesthesia or deep sedation has been reported, rarely, in people taking Mounjaro [1]. Let the surgeon and the anesthesia team know about it ahead of time. The label sets no number of days to hold it beforehand and no restart date, so go by your procedure team. Coming off the drug is covered on stopping Mounjaro.

Call your prescriber or 911

Stop Mounjaro and call your prescriber for severe stomach pain that will not go away [1]. If you use insulin or a sulfonylurea, treat signs of low blood sugar quickly [1]. Call 911 for swelling of the face or throat or trouble breathing [1].

Other diabetes options

If Mounjaro does not suit you, Ozempic is another labeled type 2 diabetes option; Ozempic vs Mounjaro compares them. Trial averages are on Mounjaro results, side effects on Mounjaro side effects, and prices on Mounjaro cost.

Questions people ask

What medicines should not be taken with Mounjaro?

Per the Zepbound label, tirzepatide is not recommended with other tirzepatide products or GLP-1 medicines [2]. The Mounjaro label also asks for extra care with insulin and sulfonylureas (low blood sugar), birth control pills (backup method needed) and narrow-margin drugs such as warfarin [1].

Is metformin safe to take with Mounjaro?

Metformin is not listed as an interaction on the Mounjaro label. The diabetes medicines it flags are insulin and sulfonylureas [1].

Does Mounjaro make birth control pills less effective?

It can. The peak level of ethinyl estradiol fell 59%. Use a non-oral method or add a barrier method for 4 weeks after starting and after each dose increase [1].

Can Mounjaro be used during pregnancy?

The label allows it only if the potential benefit justifies the potential risk to the fetus [1].

Is Mounjaro safe while breastfeeding?

In a study of 11 nursing mothers, tirzepatide in milk was undetectable or under 0.02% of the mother's dose; there are no data on infants [3]. Decide with your prescriber.

Is Mounjaro for diabetes or for weight loss?

Diabetes. It is approved for type 2 diabetes and for heart risk reduction in type 2 diabetes [1]. Zepbound is the version labeled for weight management [2].

Can people with type 1 diabetes use Mounjaro?

Type 1 diabetes is not a labeled use; the label covers type 2 diabetes [1].

Does Mounjaro harm the kidneys or liver?

No dose change is recommended for kidney or liver impairment, but dehydration from stomach side effects has caused acute kidney injury [1].

Is Tylenol OK with Mounjaro?

The label does not say to avoid it. Acetaminophen's peak level fell 50% after a first 5 mg dose because absorption slowed [1]. Ask your pharmacist.

Sources

3 cited
  1. Mounjaro (tirzepatide) injection prescribing information. DailyMed, U.S. National Library of Medicine, Aug 2026.
  2. Zepbound (tirzepatide) injection prescribing information. DailyMed, U.S. National Library of Medicine, Aug 2026.
  3. Zepbound prescribing information, NDA 217806 (PDF). U.S. Food and Drug Administration, Apr 2026.

This page is general information, not medical advice. Talk with a licensed clinician about your own care.

Compare Mounjaro and Zepbound